Fluorofenidone Offers Improved Renoprotection at Early Interventions during the Course of Diabetic Nephropathy in db/db Mice via Multiple Pathways

Diabetic nephropathy (DN) remains the leading cause of end-stage renal disease (ESRD), a situation that is in part attributable to the lack of effective treatments. Fluorofenidone is a newly developed reagent with anti-fibrotic activity. While fluorofenidone was previously demonstrated to possess re...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Xuan, Mei, Wenjuan, Xie, Yanyun, Liu, Jishi, Lu, Miaomiao, Peng, Xiongqun, Yang, Congyin, Zhang, Xin, Xie, Mingyan, Luo, Renna, Yuan, Xiangning, Huang, Ling, Wu, Lin, Qin, Jiao, Peng, Yu, Jia, Xiujie, Hu, Gaoyun, Tang, Damu, Tao, Lijian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210223/
https://www.ncbi.nlm.nih.gov/pubmed/25347392
http://dx.doi.org/10.1371/journal.pone.0111242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210223/
https://www.ncbi.nlm.nih.gov/pubmed/25347392
http://dx.doi.org/10.1371/journal.pone.0111242

Ejemplares similares